Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
| Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
|---|---|---|---|---|---|---|---|---|
| CAP29 | Communication and Care Coordination | Turnaround Time (TAT) - Lactate | Process | Registry | Details | |||
| CAP30 | Communication and Care Coordination | Urinary Bladder Biopsy Diagnostic Requirements For Appropriate Patient Management | Process | Registry | Details | |||
| CAP31 | Communication and Care Coordination | Endometrial Carcinoma Testing for MMR, MSI, or Both | Process | Registry | Details | |||
| CAP32 | Communication and Care Coordination | Prostate Cancer Gleason Pattern, Score, and Grade Group | Process | Registry | Details | |||
| CAP9 | Communication and Care Coordination | Turnaround Time (TAT) - Troponin | Process | Registry | Details | |||
| FORCE21 | Person and Caregiver Centered Experience and Outcomes | Review of Pain Status Assessment for Patients with Osteoarthritis | Outcome | Registry | Details | |||
| WCHQ10 | Effective Clinical Care | Diabetes Care All or None Outcome Measure: Optimal Control | Intermediate Outcome | Registry | Details | |||
| WCHQ15 | Effective Clinical Care | Screening For Osteoporosis | Process | Registry | Details | |||
| WCHQ32 | Effective Clinical Care | Controlling High Blood Pressure: eGFR Test Annually | Process | Registry | Details | |||
| WCHQ9 | Effective Clinical Care | Diabetes Care All or None Process Measure: Optimal Testing | Process | Registry | Details | |||
| PIMSH1 | Communication and Care Coordination | Oncology: Advance Care Planning in Metastatic Cancer Patients | Patient Engagement Experience | Registry | Details | |||
| PIMSH10 | Patient Safety | Oncology: Hepatitis B Serology Testing and Prophylactic Treatment Prior to receiving anti-CD20 targeting drugs | Process | Registry | Details | |||
| PIMSH11 | Efficiency and Cost Reduction | Oncology: Utilization of PET, PET/CT, or CT scans for Breast Cancer stage 0, I, or II at any time during the course of evaluation and treatment | Process | Registry | Details | |||
| PIMSH4 | Person and Caregiver Centered Experience and Outcomes | Oncology: Patient-Reported Pain Improvement | Outcome | Registry | Details | |||
| PIMSH8 | Effective Clinical Care | Oncology: Mutation Testing for Lung Cancer Completed Prior to Start of Targeted Therapy | Process | Registry | Details | |||
| PIMSH9 | Effective Clinical Care | Oncology: Supportive Care Drug Utilization in Last 14 Days of Life | Efficiency | Registry | Details | |||
| ONSQIR21 | Person and Caregiver Centered Experience and Outcomes | Patient Reported Health-Related Quality of Life (HRQoL) during Treatment for Advanced Cancer | Outcome | Registry | Details | |||
| ONSQIR22 | Effective Clinical Care | PCR Test with MR2 or greater result (BCR-ABL1 transcript level <= 1% [IS]) for patients receiving TKI for at least 6 months for Chronic Myelogenous Leukemia | Intermediate Outcome | Registry | Details | |||
| ONSQIR23 | Effective Clinical Care | Assessment for and management of immune-related adverse events during cancer treatment with checkpoint inhibitors (ICPi) | Intermediate Outcome | Registry | Details | |||
| PINC55 | Effective Clinical Care | Appropriate Documentation of a Malnutrition Diagnosis | Process | Registry | Details |